Micro Medical Solutions Appoints Board of Directors
Woburn, MA– March 19, 2025 – Micro Medical Solutions (MMS), a pioneering medical device startup focused on revolutionizing the treatment of Critical Limb Ischemia (CLI), is…
Read moreWoburn, MA– March 19, 2025 – Micro Medical Solutions (MMS), a pioneering medical device startup focused on revolutionizing the treatment of Critical Limb Ischemia (CLI), is…
Read moreClinical investigators complete record enrollment in real-world Registry, HEAL (An All-comers Registry of the MicroStent PeripHeral Vascular StEnt in subjects with PeripherAl ArteriaL Disease) WILMINGTON, Mass.,…
Read moreBest Practices and Outcomes for Primary Treatment or Bailout in European HEAL Observational Study Marco Manzi, MD1; Lieven Maene, MD2; Michael Lichtenberg, MD3; Wouter Lansink, MD4;…
Read moreBreakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. WILMINGTON, Mass., May 4, 2021 /PRNewswire/ — Micro Medical Solutions…
Read moreThe 2.5 mm stent will make it possible for more patients with CLI to be treated, reducing the rate of amputation. WILMINGTON, Mass., October 13, 2020…
Read moreMajor milestone reached in journey toward FDA approval for potentially limb-saving treatment of peripheral artery disease WILMINGTON, Mass., May 12 , 2020 — Micro Medical Solutions…
Read moreClinical investigators will study the safety and efficacy of this microvascular device designed to restore blood flow and reduce amputations resulting from below the knee peripheral…
Read moreAs MMS prepares for approval of their pivotal clinical trial of the company’s flagship MicroStent device, one of healthcare’s top growth experts will help shape the…
Read moreThe company establishes networks to deliver this critical technology following recent approvals in the EU and Latin America. WILMINGTON, Mass., March 12, 2019 — Micro Medical…
Read moreWith a longer, more robust access system and new stent sizes, physicians have more options to access and open arteries affected by critical limb ischemia and…
Read moreA clinical trial is underway for the MicroStent microvascular device, which is designed to open occluded arteries and prevent below-the-knee amputations. WILMINGTON, Massachusetts, June 7, 2018…
Read moreTo accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery…
Read moreWilmington, MA April 11, 2018—Micro Medical Solutions (MMS) is positioning itself for growth and product commercialization with the recent addition of two new employees to its…
Read more